Eloxx Pharmaceuticals, Inc. (ELOX) Financials
ELOX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 6.0 million | 26.1 million |
2023-06-30 | 6.0 million | 24.6 million |
2023-03-31 | 7.2 million | 23.5 million |
2022-12-31 | 21.1 million | 31.8 million |
ELOX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.5 million | 418000 |
2023-06-30 | -2.1 million | 610000 |
2023-03-31 | -6.8 million | 597000 |
2022-12-31 | -5.7 million | 641000 |
ELOX Net Income
No data available :(
ELOX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 4.8 million | - | 318000 |
2023-06-30 | 4.3 million | - | 496000 |
2023-03-31 | 4.9 million | - | 673000 |
2022-12-31 | 19.2 million | - | 847000 |
ELOX Shares Outstanding
ELOX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.3 million | 2.4 million | - |
2023-06-30 | - | 2.3 million | 1.8 million | - |
2023-03-31 | - | 3.5 million | 2.0 million | - |
2022-12-31 | 18000 | 3.3 million | 2.7 million | - |
ELOX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
ELOX
Price: $0.85
52 week price:
Earnings Per Share: -9.68 USD
P/E Ratio: -0.10
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 67300
Market Capitalization: 3.4 million